Healthcare -
Biotechnology - NASDAQ - US
$ 6.27
-11.6 %
$ 53.7 M
Market Cap
-0.45
P/E
KPTI - REVENUE
Revenue KPTI - Karyopharm Therapeutics Inc.
145 M
LAST VALUE
-3.84%
2 YEAR CAGR
28.85%
5 YEAR CAGR
90.64%
10 YEAR CAGR